Tofacitinib vs methotrexate in Takayasu arthritis

被引:0
|
作者
Thorley, Jennifer
机构
来源
LANCET RHEUMATOLOGY | 2021年 / 3卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E688 / E688
页数:1
相关论文
共 50 条
  • [31] Clinical efficacy of combination therapy of prospidin and methotrexate vs monotherapy of methotrexate for rheumatoid arthritis
    Nemtsov, BF
    Simonova, OV
    Politova, NN
    Benenson, EV
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 168 - 168
  • [32] TIME TO DISCONTINUATION OF TOFACITINIB AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT METHOTREXATE: DATA FROM A RHEUMATOID ARTHRITIS COHORT
    Movahedi, M.
    Cesta, A.
    Li, X.
    Keystone, E.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 131 - 131
  • [33] Time to Discontinuation of Tofacitinib and TNF inhibitors in Rheumatoid Arthritis Patients with and without Methotrexate: Data from A Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1127 - 1127
  • [34] Phase II Study of Tofacitinib (CP-690,550) Combined With Methotrexate in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
    Tanaka, Yoshiya
    Suzuki, Makoto
    Nakamura, Hiroyuki
    Toyoizumi, Shigeyuki
    Zwillich, Samuel H.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (08) : 1150 - 1158
  • [35] Methotrexate-Induced Pneumonitis in Rheumatoid Arthritis Long-term Treatment With Tofacitinib Therapy
    Vinicki, Juan Pablo
    Papagno, Maria Julia
    Estevez, Adrian Jorge
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S426 - S427
  • [36] ECONOMIC EVALUATION OF TOFACITINIB AS INITIAL MEDICATION IN ADULTS WITH RHEUMATOID ARTHRITIS AFTER FAILURE TO METHOTREXATE IN CHILE
    Velasquez, Z. M.
    Bustos Medina, L.
    De la Puente, A. C.
    Zaror, S. C.
    Gutierrez-Ardila, M., V
    VALUE IN HEALTH, 2015, 18 (03) : A161 - A161
  • [37] The Effect of Tofacitinib on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
    Kume, Kensuke
    Amano, Kanzo
    Yamada, Susumu
    Kanazawa, Toshikatsu
    Hatta, Kazuhiko
    Kuwaba, Noriko
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] Herpes zoster in tofacitinib-treated rheumatoid arthritis patientsaccording to concomitant glucocorticoid and methotrexate use
    Curtis, Jeffry R.
    Xie, Fenglong
    Chen, Lang
    Yun, Huifeng
    Bernatsky, Sasha
    Winthrop, Kevin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 192 - 192
  • [39] Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
    Nash, Peter
    Mease, Philip J.
    Fleishaker, Dona
    Wu, Joseph
    Coates, Laura C.
    Behrens, Frank
    Gladman, Dafna D.
    Kivitz, Alan J.
    Wei, James C.
    Shirinsky, Ivan
    Menon, Sujatha
    Romero, Ana B.
    Fallon, Lara
    Hsu, Ming-Ann
    Wang, Cunshan
    Kanik, Keith S.
    LANCET RHEUMATOLOGY, 2021, 3 (01): : E28 - E39
  • [40] Tofacitinib for Psoriatic Arthritis
    Aletaha, Daniel
    Kerschbaumer, Andreas
    Smolen, Josef S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08): : 775 - 775